Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN101153030B details a novel photochemical route from abundant triterpenoids to chiral decalin intermediates, offering significant cost reduction and supply chain stability for fragrance and pharmaceutical manufacturing.
Patent CN119707868A details a novel synthesis for Viloxazine Impurity C enabling high-purity quality control and streamlined supply chain management for global pharmaceutical manufacturers.
Patent CN107176948B details a safer pimobendan route eliminating toxic reagents. This offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Patent CN110483460A reveals a room-temperature PIFA oxidation method for 3-selenocoumarin. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Patent CN111925312A reveals a novel one-pot synthesis for indolyl-substituted indole-3-ketones using PPh3. This method offers significant cost reduction in API manufacturing and high purity.
Patent CN109518211B details a green electrochemical route to aromatic acyl compounds, eliminating metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113667006B reveals a novel liquid-phase route for Semaglutide intermediates offering high purity and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN119285532B reveals a novel five-step synthesis route offering cost reduction and scalable production for high-purity pharmaceutical intermediates.
Patent CN107793351A reveals advanced C-H amination for beta amino acids. Enables cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains globally.
Patent CN103044238A reveals a mild, high-yield route for calcium 3-methyl-2-oxovalerate, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Discover the patented purification method for Chlorin e6 achieving >99% purity. A scalable, cost-effective solution for photodynamic therapy intermediates.
Patent CN110343087B details a cobalt-catalyzed C-H activation method for isoindolinone derivatives, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN113402361A introduces a novel hypervalent iodine reagent for direct gem-difluorovinylation, offering streamlined synthesis and cost reduction in pharmaceutical intermediate manufacturing.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Novel copper complex synthesis offers enhanced antitumor activity and scalable manufacturing processes for global pharmaceutical supply chains.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Novel electrochemical method for 2-phenylpropionic acid using DMC and Mg. High purity, mild conditions, green solvent system for loxoprofen sodium production.